Phase II evaluation of single agent carboplatin in advanced thyroid carcinoma
Journal articles
- Journal Article
Ong, ST; de Groot, LJ; Vogelzang, NJ
Published in: Oncology Reports
January 1, 1994
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Oncology Reports
ISSN
1021-335X
Publication Date
January 1, 1994
Volume
1
Issue
6
Start / End Page
1217 / 1218
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ong, S. T., de Groot, L. J., & Vogelzang, N. J. (1994). Phase II evaluation of single agent carboplatin in advanced thyroid carcinoma. Oncology Reports, 1(6), 1217–1218.
Ong, S. T., L. J. de Groot, and N. J. Vogelzang. “Phase II evaluation of single agent carboplatin in advanced thyroid carcinoma.” Oncology Reports 1, no. 6 (January 1, 1994): 1217–18.
Ong ST, de Groot LJ, Vogelzang NJ. Phase II evaluation of single agent carboplatin in advanced thyroid carcinoma. Oncology Reports. 1994 Jan 1;1(6):1217–8.
Ong, S. T., et al. “Phase II evaluation of single agent carboplatin in advanced thyroid carcinoma.” Oncology Reports, vol. 1, no. 6, Jan. 1994, pp. 1217–18.
Ong ST, de Groot LJ, Vogelzang NJ. Phase II evaluation of single agent carboplatin in advanced thyroid carcinoma. Oncology Reports. 1994 Jan 1;1(6):1217–1218.
Published In
Oncology Reports
ISSN
1021-335X
Publication Date
January 1, 1994
Volume
1
Issue
6
Start / End Page
1217 / 1218
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology